Bacteria-Responsive Core-Shell Nanofibers for Wound Dressings
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antibacterial wound dressings often release antibacterial agents continuously, leading to unnecessary cytotoxicity and depletion before bacterial infection occurs, making them ineffective and potentially delaying healing.
Innovation Solution
Development of core-shell nanofibers with a biocompatible polymer core containing an antibacterial agent and a bacterially degradable polymer shell, which releases the agent only in response to bacterial activity, such as lipase secretion and pH drop, ensuring targeted and prolonged antibacterial activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibacterial agents are released continuously from wound dressings, then antibacterial protection is provided, but cytotoxicity increases and healing is delayed
Solution Approach 1:
The nanofiber system transitions from static continuous release to dynamic responsive release, where the shell structure dynamically responds to bacterial presence by degrading and releasing the antibacterial agent only when bacteria are detected, thereby eliminating unnecessary cytotoxicity while maintaining reliable antibacterial protection
Solution Approach 2:
The system changes the release parameter from continuous constant release to conditional variable release based on bacterial presence. The shell's degradation state changes in response to bacterial enzymes, altering the release kinetics to match actual therapeutic needs and reduce harmful cytotoxic effects
2Reliability
If antibacterial agents are released continuously, then initial antibacterial effect is achieved, but agent depletion occurs before bacterial infection
Solution Approach 1:
The antibacterial agent is pre-loaded and protected within the core structure during the dressing application period. The shell acts as a preliminary barrier that prevents premature release, ensuring the agent remains available and effective until actually needed when bacterial infection occurs
Solution Approach 2:
The degradable shell serves as an intermediary structure between the antibacterial agent and the external environment. It mediates the release process by degrading in response to bacterial presence, thereby controlling timing and ensuring the agent is released only when required for maximum efficacy
3Device complexity
If indiscriminant elution is used, then simple system design is maintained, but targeted antibacterial action is lost
Solution Approach 1:
The system uses a composite core-shell structure where the shell material is specifically selected for its bacterial-responsive degradation properties. This composite design adds targeted functionality without excessive complexity, combining a biocompatible core with a bacterially-degradable shell to achieve adaptive release
Solution Approach 2:
The nanofiber system performs self-detection and self-response to bacterial presence. The shell automatically degrades in response to bacterial enzymes without requiring external control mechanisms, providing adaptive targeted release while maintaining relative system simplicity through self-service functionality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The core-shell nanofibers provide controlled and efficient release of antibacterial agents, reducing cytotoxicity and maintaining high fibroblast viability, while effectively inhibiting bacterial growth and preventing wound infections.
Implementation Method 1
a shell surrounding the core comprising a bacterially degradable polymer
Implementation Method 2
bacterial activity, such as lipase secretion
Implementation Method 3
pH drop
Implementation Method 4
coaxially electrospinning a fiber from a core material within a shell material
Data Source
AI summary
Bacteria-responsive core-shell nanofibers and a process for the preparation thereof are described. The nanofibers release of an antibacterial agent in response to the presence of bacteria. The core of the nanofiber comprises a biocompatible polymer together with an antibacterial agent such as a quaternary ammonium compound, for example benzyl dimethyl tetradecyl ammonium chloride (BTAC). Surrounding the core is shell comprised of a bacterially degradable polymer, which is susceptible to break-down by bacterial enzymes such as lipase, or to acidic pH conditions. The shell may comprise, for example, polycaprolactone (PCL) and poly(ethylene succinate) (PES). The nanofibers may be incorporated into wound dressings.